Stock screener

BHC

Conviction 8HealthcareScan · Thu, Jun 25, 2026
BHC$5.28+5.71%
ResistanceSupportVol 14Insider sell
63 bars
Vol MA14 2.22M
Mar 26Apr 14May 1May 19Jun 8Jun 25
Bausch Health Companies Inc.PHARMACEUTICAL PREPARATIONSwww.bauschhealth.com
Price5.28
Change+5.71%
Gap+1.20%
Rel volume1.39×
Avg volume2.32M
Avg $ vol11.72M
SMA 205.08
SMA 505.38
SMA 2006.07
Price vs 50-1.88%
Price vs 200-13.06%
MA stackbearish
50/200 cross
Supertrenddown · 5.29
RSI (14)55
MACD hist0.02
MACD crossbull · 0d
Stoch %K / %D84 / 55
ADX (14)15
+DI / −DI31 / 21
RSI divergence
MACD divergenceBullish
ATR %+4.23%
ADR %4.07%
52w high8.34
52w low4.67
From 52w high-36.75%
Above 52w low+12.96%
New 52w highNo
SqueezeOff
Bollinger width16.83%
%B0.73
Donchian pos78.45%
Donchian high5.47
Donchian low4.57
AVWAP (52w high)6.28
vs AVWAP high-15.97%
AVWAP (52w low)4.87
vs AVWAP low+8.35%
OBV trendFlat
Chaikin MF (20)-0.07
Today vs 20d1.39×
Avg vol (14d)2.22M
Avg vol (20d)2.32M
Avg $ vol (20d)11.72M
Market cap1.97B
RS 3m (vs SPY)-12.26%
RS 6m (vs SPY)-35.21%
RS line new highNo
Trend template0/8
Technical rank29.1
1 week+10.82%
1 month-2.31%
3 months+3.84%
6 months-24.54%
1 year-14.92%
YTD-26.84%
P/E12.55
P/B-0.96
P/S0.19
P/FCF1.96
EPS0.4200
Div yield18.09%
ROE-7.63%
ROA0.64%
Debt/Eq-10.08
Current1.32
EV/EBITDA7.10
Gross margin
Net margin1.53%
Rev growth6.66%
EPS growth441.30%
Price target7.67
Target upside45.40%
Analyst ratingHold
Institutional66.54%
Ent. value21.44B
Revenue2.52B
Net income-1.42B
Gross profit
Free cash flow1B
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNYSE
Shares out374.02M
Employees20.3K
ListedThu, Mar 31, 1994
Free float262.07M
Float %70.3%
Short interest6.12M
Days to cover3.8d
Short volume42.7%
Squeeze score31 / 100
Next earningsWed, Jul 29, 2026 (34d)
EPS forecast$0.96 · 2 est
Last EPS vs est$0.78 vs $0.81
Last surprise-3.7% miss
Setup gradeD
Conviction8 / 100
Pattern quality
Tech rank29.1 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction
Pattern family
Resistance5.75
Support4.75
Days since event
Candle confirm
News sentiment

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in BHC

All disclosures →
No recent disclosed trades by Congress in BHC. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in BHC · 9 buys

InsiderSideShares
LEUNG SANDRA
Director · Common Shares, No Par Value · 2026-05-22
Grant45.87K
Garcia Christian A
Director · Common Shares, No Par Value · 2026-05-22
Grant45.87K
ROBERTS EIRY
Director · Common Shares, No Par Value · 2026-05-22
Grant45.87K
Lee Frank D.
Director · Common Shares, No Par Value · 2026-05-22
Grant45.87K
WECHSLER AMY B
Director · Common Shares, No Par Value · 2026-05-22
Grant45.87K
Paulson John
Director · Common Shares, No Par Value · 2026-05-22
Other
POWER ROBERT N
Director · Common Shares, No Par Value · 2026-05-22
Grant45.87K
GOETTLER MICHAEL
Director · Common Shares, No Par Value · 2026-05-22
Grant45.87K
Paulson John
Director · Common Shares, No Par Value · 2026-05-22
Grant45.87K
KAVANAGH SARAH B
Director · Common Shares, No Par Value · 2026-05-22
Grant45.87K

SEC filings

EDGAR filings in BHC

EDGAR →

No recent SEC filings on file for BHC.

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.